AgenT
AgenT is developing the first blood diagnosis to detect Alzheimer's disease early, up to 20 years before irreversible symptoms appear. Their mission is to enable early detection through a multiomics platform that combines machine learning and biomarkers signals, aiming to prevent or stop the progression of Alzheimer's. They collaborate with leading academic medical centers and are engaged in clinical research and partnerships to validate their innovative diagnostic approach.
Industries
Nr. of Employees
small (1-50)
AgenT
STATION F, 14 rue Eugène Freyssinet 75013 Paris, FRANCE
Products
Blood-based multiomics diagnostic test for early Alzheimer's detection
A diagnostic approach that analyses plasma proteins and metabolites and applies machine learning to detect Alzheimer's-associated biomarker patterns across asymptomatic, prodromal and dementia stages from routine blood draws.
Blood-based multiomics diagnostic test for early Alzheimer's detection
A diagnostic approach that analyses plasma proteins and metabolites and applies machine learning to detect Alzheimer's-associated biomarker patterns across asymptomatic, prodromal and dementia stages from routine blood draws.
Services
Design and execution of retrospective, multi-site studies to validate multiomics biomarkers in archived plasma samples across disease stages.
Partnership formation to enable shared research projects, access to clinical cohorts, and joint analytical workflows for early-detection research.
Design and execution of retrospective, multi-site studies to validate multiomics biomarkers in archived plasma samples across disease stages.
Partnership formation to enable shared research projects, access to clinical cohorts, and joint analytical workflows for early-detection research.
Expertise Areas
- Clinical trial management for biomarker studies
- Biomarker discovery and translation
- Proteomics
- Metabolomics
Key Technologies
- Proteomics (plasma protein profiling)
- Metabolomics (plasma metabolite profiling)
- Machine learning and AI for pattern recognition
- Multiomics integration
News & Updates
Press release dated July 17, 2020, about collaboration to enhance early detection of Alzheimer's.
Press release dated July 28, 2020, presenting early data on their blood test.
Press release dated June 23, 2021, about scientific collaboration.
Press release dated September 21, 2021, about the start of the APOLLO study.
Press release dated July 27, 2023, about their blood tests.
Press release about collaboration to improve early detection of Alzheimer's using machine learning.
Press release dated July 17, 2020, about collaboration to enhance early detection of Alzheimer's.
Press release dated July 28, 2020, presenting early data on their blood test.
Press release dated June 23, 2021, about scientific collaboration.
Press release dated September 21, 2021, about the start of the APOLLO study.
Press release dated July 27, 2023, about their blood tests.
Press release about collaboration to improve early detection of Alzheimer's using machine learning.